Message from Management
Leadership Team
Fact Sheet
History
Kuvan®
Naglazyme®
Aldurazyme®
Clinical Development
Preclinical Development
Manufacturing
Sales and Marketing
Partnerships
6R-BH
4
for Cardiovascular Indications
6R-BH
4
for Sickle Cell Disease
PEG-PAL for PKU
BioMarin is positioned to bring first-to-market therapeutics to people living with serious inherited metabolic disorders.
in the clinic
© 2006 BIOMARIN
LEGAL NOTICE
GLOSSARY
Last updated: 07/24/2008
